BLEEDnFIRE Therapeutics
BLEEDnFIRE Therapeutics AG
- Headquarters
- Bern
- Business Model
- B2B
- Website
- venturekick.ch
- Last Round
- GrantNov 2024
- Rounds
- 1
About
Swiss biotech developing siRNA therapies for rare bleeding disorders including hemophilia.
Summary
BLEEDnFIRE Therapeutics is a Biotech company based in Bern, Switzerland. Its most recent funding was a Grant round in Nov 2024. Investors include Venture Kick.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2024
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bleednfire-therapeutics"><img src="https://indexed.vc/api/badge/company/bleednfire-therapeutics" alt="BLEEDnFIRE Therapeutics on Indexed.vc" width="260" height="76" /></a>